scholarly article | Q13442814 |
P2093 | author name string | Abel Romero-Corral | |
Virend K Somers | |||
John A Batsis | |||
Maria L Collazo-Clavell | |||
Michael G Sarr | |||
Francisco Lopez-Jimenez | |||
Lee Brekke | |||
P2860 | cites work | Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish Obese Subjects (SOS) Intervention Study | Q47212556 |
Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. | Q47219708 | ||
Intentional weight loss and mortality among overweight individuals with diabetes | Q47227882 | ||
Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study | Q47256275 | ||
Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years | Q47269504 | ||
Report of a National Institutes of Health--Centers for Disease Control and Prevention workshop on the feasibility of conducting a randomized clinical trial to estimate the long-term health effects of intentional weight loss in obese persons | Q47269875 | ||
Effects of weight reduction on arterial pressure | Q47272023 | ||
Voluntary and involuntary weight loss: associations with long term mortality in 9,228 middle-aged and elderly men. | Q47280791 | ||
Weight loss and mortality | Q47386928 | ||
Prevalence and secular trends of excess body weight and impact on outcomes after myocardial infarction in the community | Q47423164 | ||
Bariatric surgery for morbid obesity. | Q48710874 | ||
The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. | Q50855237 | ||
Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. | Q51568331 | ||
Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. | Q53489244 | ||
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update | Q58975659 | ||
Obesity and Heart Disease | Q61440813 | ||
Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation | Q61779932 | ||
Overweight and obesity in the United States: prevalence and trends, 1960-1994 | Q64133342 | ||
Cardiovascular disease and multifactorial risk: challenge of the 1980s | Q71090189 | ||
Very low cholesterol and cholesterol lowering. A statement for healthcare professionals from the American Heart Association Task Force on Cholesterol Issues | Q72791855 | ||
Significant Changes in the Lipid-Lipoprotein Status of Premenopausal Morbidly Obese Females following Gastric Bypass Surgery | Q73609436 | ||
The Swedish Obese Subjects (SOS) study--rationale and results | Q74244841 | ||
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease | Q74314523 | ||
Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies | Q78015398 | ||
Impact of gastric bypass operation on survival: a population-based analysis | Q80799557 | ||
Recognition, diagnosis and management of obesity after myocardial infarction | Q80947208 | ||
Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures | Q81370594 | ||
Obesity in Adulthood and Its Consequences for Life Expectancy: A Life-Table Analysis | Q22241144 | ||
Annual Deaths Attributable to Obesity in the United States | Q22253003 | ||
Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus | Q24535547 | ||
Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients | Q24540153 | ||
Report of the Conference on Low Blood Cholesterol: Mortality Associations | Q28183069 | ||
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
Meta-analysis: surgical treatment of obesity | Q28243512 | ||
NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel | Q28248503 | ||
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery | Q29614192 | ||
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 | ||
Prediction of coronary heart disease mortality in blacks and whites: pooled data from two national cohorts | Q30579261 | ||
Bariatric surgery: a systematic review and meta-analysis | Q30769299 | ||
Obesity and coronary heart disease | Q34222123 | ||
Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. | Q34327135 | ||
History of the Rochester Epidemiology Project | Q34374377 | ||
Excess deaths associated with underweight, overweight, and obesity | Q34412581 | ||
Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years | Q34722458 | ||
Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. | Q34752127 | ||
Weight loss causes increased mortality: cons | Q35074205 | ||
Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis | Q35346665 | ||
Does intentional weight loss affect mortality rate? | Q35682576 | ||
Surgery for severe obesity | Q35688274 | ||
Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the Ameri | Q35847375 | ||
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Ph | Q36354637 | ||
Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale | Q38505802 | ||
National trends in utilization and in-hospital outcomes of bariatric surgery | Q40613345 | ||
The association between weight loss and increased longevity. A review of the evidence | Q40841419 | ||
Long-term effects of change in body weight on all-cause mortality. A review | Q40841426 | ||
Is weight loss hazardous? | Q41028435 | ||
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation | Q43742848 | ||
Midlife body mass index and hospitalization and mortality in older age. | Q44676822 | ||
Secular trends in cardiovascular disease risk factors according to body mass index in US adults | Q46446083 | ||
Safety and efficacy of bariatric surgery in patients with coronary artery disease | Q46716056 | ||
Weight change, weight fluctuation, and mortality. | Q47174962 | ||
P433 | issue | 3 | |
P921 | main subject | cardiac surgery | Q235007 |
bariatric surgery | Q357503 | ||
P304 | page(s) | 772-784 | |
P577 | publication date | 2007-03-01 | |
P1433 | published in | Obesity | Q15763232 |
P1476 | title | Effect of weight loss on predicted cardiovascular risk: change in cardiac risk after bariatric surgery | |
P478 | volume | 15 |
Q37274649 | Cardiovascular risk after bariatric surgery for obesity |
Q33586716 | Cardiovascular risk assessment--from individual risk prediction to estimation of global risk and change in risk in the population |
Q96304069 | Case Report: Acute kidney failure leading to permanent haemodialysis due to hyperoxaluria following one-anastomosis gastric bypass-related rapid weight loss |
Q44497798 | Change in predicted 10-year cardiovascular risk following Roux-en-Y gastric bypass surgery: who benefits? |
Q40059184 | Change in predicted 10-year cardiovascular risk following laparoscopic Roux-en-Y gastric bypass surgery |
Q36327719 | Effect of bariatric surgery on cardiometabolic risk in elderly patients: A population-based study |
Q42222532 | Effect of bariatric surgery on hypertension: a meta-analysis. |
Q37272291 | Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study |
Q34097365 | Feasibility of bariatric surgery as a strategy for secondary prevention in cardiovascular disease: a report from the Swedish obese subjects trial. |
Q34481653 | Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study |
Q34492524 | Interactions between obesity and obstructive sleep apnea: implications for treatment |
Q43943958 | Long-term effects of a multidisciplinary treatment of uncomplicated obesity on carotid intima-media thickness |
Q38252801 | Long-term effects of bariatric surgery on type II diabetes, hypertension and hyperlipidemia: a meta-analysis and meta-regression study with 5-year follow-up |
Q36939259 | Metabolic syndrome: from global epidemiology to individualized medicine |
Q43148669 | One year improvements in cardiovascular risk factors: a comparative trial of laparoscopic Roux-en-Y gastric bypass vs. adjustable gastric banding |
Q92044310 | Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies |
Q46107003 | Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery |
Q47184291 | Predicted Coronary Heart Disease Risk Decreases in Obese Patients After Laparoscopic Sleeve Gastrectomy |
Q37640724 | Predictors of total morbidity burden on days 3, 5 and 8 after cardiac surgery |
Q26830659 | Reductions in cardiovascular risk after bariatric surgery |
Q40581791 | Renal Function and Remission of Hypertension After Bariatric Surgery: a 5-Year Prospective Cohort Study. |
Q46269853 | Resolution of systemic hypertension after laparoscopic gastric bypass |
Q48585140 | Risk perception of obesity and bariatric surgery in patients seeking treatment for obesity. |
Q45181497 | Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients |
Q37426315 | Trends in 10-year predicted risk of cardiovascular disease in the United States, 1976 to 2004 |
Search more.